Your browser doesn't support javascript.
loading
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.
Tippalagama, Rashmi; Singhania, Akul; Dubelko, Paige; Lindestam Arlehamn, Cecilia S; Crinklaw, Austin; Pomaznoy, Mikhail; Seumois, Gregory; deSilva, Aruna D; Premawansa, Sunil; Vidanagama, Dhammika; Gunasena, Bandu; Goonawardhana, N D Suraj; Ariyaratne, Dinuka; Scriba, Thomas J; Gilman, Robert H; Saito, Mayuko; Taplitz, Randy; Vijayanand, Pandurangan; Sette, Alessandro; Peters, Bjoern; Burel, Julie G.
Afiliação
  • Tippalagama R; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Singhania A; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Dubelko P; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Lindestam Arlehamn CS; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Crinklaw A; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Pomaznoy M; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Seumois G; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • deSilva AD; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Premawansa S; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Vidanagama D; Faculty of Science, University of Colombo, Colombo, Sri Lanka.
  • Gunasena B; National Tuberculosis Reference Laboratory, Welisara, Sri Lanka.
  • Goonawardhana NDS; National Hospital for Respiratory Diseases, Welisara, Sri Lanka.
  • Ariyaratne D; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Scriba TJ; Faculty of Medicine, General Sir John Kotelawala Defense University, Ratmalana, Sri Lanka.
  • Gilman RH; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Saito M; Johns Hopkins School of Public Health, Baltimore, MD.
  • Taplitz R; Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Vijayanand P; Department of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sette A; Department of Medicine, City of Hope National Medical Center, Duarte, CA; and.
  • Peters B; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA.
  • Burel JG; Department of Medicine, University of California San Diego, La Jolla, CA.
J Immunol ; 207(2): 523-533, 2021 07 15.
Article em En | MEDLINE | ID: mdl-34193602
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article